Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer
Clinical trial NCT02225405 · COMPLETED
Trial details
- NCT number
- NCT02225405
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-03
- Primary completion
- 2024-05-06
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.